From gonirfsttoq@bloodscorn.com Tue May 20 11:20:00 2008 Received: with ECARTIS (v1.0.0; list jessie); Tue, 20 May 2008 11:20:03 -0700 (PDT) Received: from cuda.sgi.com (cuda1.sgi.com [192.48.168.28]) by oss.sgi.com (8.12.11.20060308/8.12.11/SuSE Linux 0.7) with ESMTP id m4KIJxBD015027 for ; Tue, 20 May 2008 11:20:00 -0700 X-ASG-Debug-ID: 1211307644-5ea8023c0000-hEU9jj X-Barracuda-URL: http://cuda.sgi.com:80/cgi-bin/mark.cgi Received: from roxy.localnet.localdomain (localhost [127.0.0.1]) by cuda.sgi.com (Spam Firewall) with ESMTP id 93465BA4B2C for ; Tue, 20 May 2008 11:20:45 -0700 (PDT) Received: from roxy.localnet.localdomain ([86.105.14.40]) by cuda.sgi.com with ESMTP id 5t6fzEGfIwrGBO5i for ; Tue, 20 May 2008 11:20:45 -0700 (PDT) Received: from [86.105.14.40] by mx-cluster1.one.com; Tue, 20 May 2008 20:20:48 +0200 From: "Phil Oakley" To: X-ASG-Orig-Subj: Your insatiable chick will be full of pleasure Subject: Your insatiable chick will be full of pleasure Date: Tue, 20 May 2008 20:20:48 +0200 Message-ID: <01c8bab6$fd819000$280e6956@gonirfsttoq> MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_0006_01C8BAB6.FD819000" X-Priority: 3 (Normal) X-MSMail-Priority: Normal X-Mailer: Microsoft Outlook, Build 10.0.4115 X-MimeOLE: Produced By Microsoft MimeOLE V5.50.4807.2300 Importance: Normal X-Barracuda-Connect: UNKNOWN[86.105.14.40] X-Barracuda-Start-Time: 1211307649 X-Barracuda-Bayes: INNOCENT GLOBAL 0.5053 1.0000 0.7500 X-Barracuda-Virus-Scanned: by cuda.sgi.com at sgi.com X-Barracuda-Spam-Score: 1.45 X-Barracuda-Spam-Status: No, SCORE=1.45 using per-user scores of TAG_LEVEL=2.0 QUARANTINE_LEVEL=1000.0 KILL_LEVEL=2.1 tests=HTML_MESSAGE, MARKETING_SUBJECT, RDNS_NONE X-Barracuda-Spam-Report: Code version 3.1, rules version 3.1.50927 Rule breakdown below pts rule name description ---- ---------------------- -------------------------------------------------- 0.60 MARKETING_SUBJECT Subject contains popular marketing words 0.00 HTML_MESSAGE BODY: HTML included in message 0.10 RDNS_NONE Delivered to trusted network by a host with no rDNS X-archive-position: 1014 X-ecartis-version: Ecartis v1.0.0 Sender: jessie-bounce@oss.sgi.com Errors-to: jessie-bounce@oss.sgi.com X-original-sender: gonirfsttoq@bloodscorn.com Precedence: bulk X-list: jessie This is a multi-part message in MIME format. ------=_NextPart_000_0006_01C8BAB6.FD819000 Content-Type: text/plain; charset="windows-1250" Content-Transfer-Encoding: 7bit {Cialis_html} ------=_NextPart_000_0006_01C8BAB6.FD819000 Content-Type: text/html; charset="windows-1250" Content-Transfer-Encoding: quoted-printable {Cialis_html} ------=_NextPart_000_0006_01C8BAB6.FD819000-- From newsletter@clinicaltrialmagnifier.com Wed May 21 04:31:04 2008 Received: with ECARTIS (v1.0.0; list jessie); Wed, 21 May 2008 04:31:07 -0700 (PDT) Received: from cuda.sgi.com (cuda1.sgi.com [192.48.168.28]) by oss.sgi.com (8.12.11.20060308/8.12.11/SuSE Linux 0.7) with ESMTP id m4LBV3t5031859 for ; Wed, 21 May 2008 04:31:03 -0700 X-ASG-Debug-ID: 1211369511-5e9f016f0002-hEU9jj X-Barracuda-URL: http://cuda.sgi.com:80/cgi-bin/mark.cgi Received: from mx1.clinicalresearchclinic.com (localhost [127.0.0.1]) by cuda.sgi.com (Spam Firewall) with ESMTP id EB2AD1195179 for ; Wed, 21 May 2008 04:31:53 -0700 (PDT) Received: from mx1.clinicalresearchclinic.com ([147.8.74.140]) by cuda.sgi.com with ESMTP id BvWkrlXtLjd60Wnl for ; Wed, 21 May 2008 04:31:53 -0700 (PDT) Received: from MIS-WW ([147.8.74.187]) by mx1.clinicalresearchclinic.com with Microsoft SMTPSVC(6.0.3790.3959); Wed, 21 May 2008 14:52:52 +0800 From: "Johan PE Karlberg" X-ASG-Orig-Subj: Recent Clinical Trial Listings & Sponsored Clinical Trials Trends Subject: Recent Clinical Trial Listings & Sponsored Clinical Trials Trends To: jessie@oss.sgi.com Content-Type: multipart/mixed; boundary="QAZX8cBROi4FRIeZxItssBXWa5wf=_k4FC" MIME-Version: 1.0 Date: Wed, 21 May 2008 14:54:52 +0800 Message-ID: X-OriginalArrivalTime: 21 May 2008 06:52:53.0156 (UTC) FILETIME=[4AA91E40:01C8BB0F] X-Barracuda-Connect: UNKNOWN[147.8.74.140] X-Barracuda-Start-Time: 1211369513 X-Barracuda-Bayes: INNOCENT GLOBAL 0.4999 1.0000 0.0000 X-Barracuda-Virus-Scanned: by cuda.sgi.com at sgi.com X-Barracuda-Spam-Score: 0.30 X-Barracuda-Spam-Status: No, SCORE=0.30 using per-user scores of TAG_LEVEL=2.0 QUARANTINE_LEVEL=1000.0 KILL_LEVEL=2.1 tests=BSF_SC0_SA074b, HTML_MESSAGE, RDNS_NONE X-Barracuda-Spam-Report: Code version 3.1, rules version 3.1.50995 Rule breakdown below pts rule name description ---- ---------------------- -------------------------------------------------- 0.20 BSF_SC0_SA074b URI: Custom Rule SA074b 0.00 HTML_MESSAGE BODY: HTML included in message 0.10 RDNS_NONE Delivered to trusted network by a host with no rDNS X-archive-position: 1015 X-ecartis-version: Ecartis v1.0.0 Sender: jessie-bounce@oss.sgi.com Errors-to: jessie-bounce@oss.sgi.com X-original-sender: newsletter@clinicaltrialmagnifier.com Precedence: bulk X-list: jessie This is a multi-part message in MIME format --QAZX8cBROi4FRIeZxItssBXWa5wf=_k4FC Content-Type: text/plain Content-Transfer-Encoding: quoted-printable From Clinical Trials Centre, The University of Hong Kong --QAZX8cBROi4FRIeZxItssBXWa5wf=_k4FC Content-Type: text/html Content-Transfer-Encoding: quoted-printable

Dear Col= league (jessie),

You are invited to subscribe to a new free electronic monthly newsl= etter, the Clinical Trial Magnifier at www.clinicaltrialmagnifier.com.

Issue 1 (Jan 2008) - West to East Drift in European Sponsored Cl= inical Trials
Issue 2 (Feb 2008) - Sponsored Clinical Trial = Globalization Trends
Issue 3 (Mar 2008) - Most Preferred Spo= nsored Clinical Trial Locations in the United States
Issue 4= (Apr 2008) - The Trail of Sponsored Clinical Trials

Yours Sincerely

Johan PE Karlberg, MD, PhD
Clinical Trials Centre
The Univers= ity of Hong Kong

P.S. If you have any kind of queries or messag= es please contact me directly using:
editorialboard@clinicaltrialmagnifier.= com

Please click here to remove your email address fro= m our database.

--QAZX8cBROi4FRIeZxItssBXWa5wf=_k4FC--